aTyr Pharma reported $48.79M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Ardelyx USD 148.62M 18.33M Mar/2026
aTyr Pharma USD 48.79M 9.15M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Cipla INR 344.32B 15.13B Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 95.35M 7.38M Mar/2026
CSL USD 18.66B 2.75B Dec/2025
Curis USD 12.71M 7.24M Mar/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Grifols EUR 6.21B 133.12M Dec/2025
Lakefront Biotherapeutics EUR 3.26B 10.26M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026